03.19.21
Ravenscroft Apothecary, Inc. (DBA Ravenscroft Escentials) has been issued a warning letter by the US Food & Drug Administration. The Grants Pass, OR-based company was cited for unapproved and misbranded products related to COVID-19.
The FDA and the Federal Trade Commission (FTC) reviewed the company’s website on March 3, 2021, and March 10, 2021, respectively, as well as its social media website at www.instagram.com/ravenscroftoils, where it was selling products including Air Purify Aromamist and Elevation of Mind Aromamist as means to mitigate, prevent, treat, diagnose, or cure COVID-19. Based on the review, these products are unapproved new drugs sold in violation of section 505(a) of the Federal Food, Drug, and Cosmetic Act (FD&C Act), 21 U.S.C. § 355(a). Furthermore, these products are misbranded drugs under section 502 of the FD&C Act, 21 U.S.C. § 352. The introduction or delivery for introduction of these products into interstate commerce is prohibited under sections 301(a) and (d) of the FD&C Act, 21 U.S.C. § 331(a) and (d).
The FDA and the Federal Trade Commission (FTC) reviewed the company’s website on March 3, 2021, and March 10, 2021, respectively, as well as its social media website at www.instagram.com/ravenscroftoils, where it was selling products including Air Purify Aromamist and Elevation of Mind Aromamist as means to mitigate, prevent, treat, diagnose, or cure COVID-19. Based on the review, these products are unapproved new drugs sold in violation of section 505(a) of the Federal Food, Drug, and Cosmetic Act (FD&C Act), 21 U.S.C. § 355(a). Furthermore, these products are misbranded drugs under section 502 of the FD&C Act, 21 U.S.C. § 352. The introduction or delivery for introduction of these products into interstate commerce is prohibited under sections 301(a) and (d) of the FD&C Act, 21 U.S.C. § 331(a) and (d).